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Abstract
Background: Pregnant women and their unborn babies are at increased risk of complications as a result of flu, yet
uptake of the flu vaccination in the UK remains low. Digital interventions have proven effectiveness in changing
health behaviour, but their effectiveness in increasing flu vaccination amongst pregnant women has not been
examined. This protocol details the design and methodology of a systematic review and meta-analysis, examining
the effectiveness of digital interventions in increasing flu vaccination amongst pregnant women.
Methods: Bibliographic databases will be searched using appropriate search terms related to vaccination,
pregnancy and flu. Randomised, non-randomised, quasi randomised controlled trials and other quantitative study
designs will be eligible for inclusion, and studies will present the rate of flu vaccination amongst pregnant women
of digital interventions compared to non-digital interventions, or usual care. No date or study country restrictions
will be put on included studies, but studies will be published in English.
Discussion: This is the first known systematic review to examine the effectiveness of digital interventions in
increasing the rate of flu vaccination amongst pregnant women. This review has the potential to inform whether
digital interventions are an appropriate and successful method of increasing flu vaccination amongst pregnant
women, and to determine which mode of digital intervention is most effective.
Trial registration: This systematic review is registered on the international prospective register of systematic
reviews (PROSPERO). Registration number pending.
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Background
Pregnant women and their unborn babies are at in-
creased risk of complications as a result of flu, with
pregnant women being at increased chance of hospital-
isation and death due to physiological and immuno-
logical changes that happen during pregnancy [1–3], and
unborn babies being at increased risk of premature birth,
stillbirth and below average birthweight as a result of
maternal flu [1]. Despite the increased risk of severe con-
sequences from flu, and despite the flu vaccination having
a good record of safety and effectiveness [4–6], uptake of
the flu vaccination in England is annually below national
targets, with 45.2% of pregnant women receiving the flu
vaccination in the 2018/2019 flu season [7].
Access to internet use has increased rapidly over re-
cent years, with 87% of all adults using the internet daily
or almost daily during 2019, and with almost two thirds
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of households in the UK having access to mobile broad-
band [8]. The popularity of internet use is expected to
continue to increase, with nearly 54 million people esti-
mated to use an internet enabled smartphone in the UK
by 2022 [9].
Digital interventions are one approach to increasing
health behaviours that often utilise internet capabilities.
Digital interventions have proven effectiveness in in-
creasing behaviours such as smoking cessation [10],
physical activity [11] and asthma self-management [12].
If digital interventions are effective in increasing flu vac-
cination amongst pregnant women, it suggests a mech-
anism for primary care services to impact the health of
pregnant women and unborn babies, and reduce associ-
ated costs resulting from maternal flu. For the purposes
of this review, the term digital behavioural interventions is
defined as an intervention that attempts to change preg-
nant women’s vaccination behaviour that are delivered via
a digital or mobile device directly to participants. This in-
cludes text messages (including text, video or audio based
messages), interventions delivered by the internet (includ-
ing by websites, mobile applications (apps) or social media
sites), or other digital strategies [13].
To date, the effectiveness of digital interventions at in-
creasing the rate of flu vaccination amongst pregnant
women have yet to be determined. This review aims to
establish whether digital interventions are effective at in-
creasing flu vaccination amongst pregnant women, and
to determine the size of the effect.
Research question
How effective are digital interventions in increasing flu
vaccination amongst pregnant women?
Objectives
1. To examine the effectiveness of digital interventions
in increasing flu vaccination amongst pregnant
women.
2. To compare the effectiveness of different types of
digital interventions in increasing flu vaccination
amongst pregnant women
Methods
Completed PRISMA-P checklist, showing recommended
items to include in a systematic review protocol, and
where in the protocol each item is located, can be found
in Additional file 1.
Eligibility criteria
Studies will be included that test the effectiveness of
digital behavioural interventions in increasing the rate of
flu vaccination amongst pregnant women. Comparators
in included studies will be either usual care, a wait-list
comparator, a historical control group where the digital
intervention is not present, a digital intervention that is
not about flu vaccination, or comparison to a non-digital
intervention. The outcome being studied is the rate of
flu vaccination amongst pregnant women. Only original
research studies will be included, with any systematic re-
views, protocols, commentaries and conference abstracts
being excluded. Included studies will be either a rando-
mised controlled trial, a non-randomised controlled trial,
quasi-randomised controlled trial or other type of quan-
titative study that reports the rate of flu vaccination (for
example, before and after trials) following the implemen-
tation of a digital intervention, which also contains a
comparator group. Quantitative studies such as case
series, case studies and case reports will also be ex-
cluded. No date or country restrictions will be placed on
the search, but studies will be required to be published
in English (Table 1).
Outcome measures
The outcome measure will be the rate of flu vaccination
amongst pregnant women after receiving a specific
digital intervention, compared to the comparator group.
This will either be self-reported flu vaccination status or
rate obtained from electronic patient records.
In studies where the main outcome is intention to vac-
cinate rather than actual vaccination behaviour (uptake
of vaccination), this rate will be used for this review.
Information sources
Electronic bibliography databases will be searched during
April and May 2020. MEDLINE, Embase, Web of Science,
Scopus, Cochrane database, PsycINFO, and Cochrane
Central Register of Controlled Trials (CENTRAL) will be
searched for all eligible studies. Clinical trial registers will
be searched for in-progress trials (e.g. ClinicalTrials.Gov)
Search terms will include all possible terms relating to
‘vaccination’, ‘influenza’, ‘pregnancy’, and variations of
‘digital interventions’ to include interventions that contain
significant influence from text messages, video, internet,
or mobile phone applications (apps) [13, 14]. Boolean
strategies of ‘AND’ and ‘OR’ will be employed.
Reference sections of included studies will also be
screened by hand to identify any other eligible studies,
and papers citing included studies will be searched.
Search strategy
Specialist advice on the search strategy has been sought in
developing the search strategy for this review, to ensure
searches are comprehensive and capture all relevant stud-
ies in the searches. An example of the full search strategy
for one database can be found in Additional file 2. Key-
words will be searched in both titles and abstracts.
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Data management and screening process
Results of searches will be managed using Endnote soft-
ware. Results from all databases will be combined, alpha-
betised and duplicates will be removed.
The first stage of screening will consist of all titles and ab-
stracts being screened. Any studies that appear to meet the
inclusion criteria will be subject to stage two of screening,
which will consist of full text screening, where full papers will
be obtained and screened against the eligibility criteria.
Screening will be conducted by two researchers independ-
ently, and any discrepancies will be resolved with discussion.
If a consensus is not reached, advice will be sought by a third
researcher, until a full and final set of studies that meet the
inclusion criteria are obtained. In addition to this, reference
sections of all included studies will be screened for any stud-
ies that were not captured by the searches.
Data will be extracted from all included studies. This will
be conducted by two researchers independently, using a pre-
defined extraction form. Eligibility for inclusion in the meta-
analysis will also be determined. The following information
will be extracted from each included study: name of author,
year of publication, study design, study setting, participants,
details about intervention (including the mode of digital
intervention such as text message, video, mobile phone app),
comparison/control condition, rate of flu vaccination, and
size of effect of intervention (if reported). Any discrepancies
between data extraction carried out by the two researchers
will be discussed, and a third author will be consulted if a
consensus is not reached.
Quality assessment
Risk of bias in Randomised Controlled Trials will be
assessed using the Cochrane Risk of Bias tool [15]. Stud-
ies will be assessed on the domains below and classified
as either low risk, medium risk, or high risk of bias:
1. Sequence generation
2. Allocation concealment
3. Blinding of participants, personnel and outcome
assessors
4. Incomplete outcome data
5. Selective outcome reporting
6. Other sources of bias
Risk of bias in non-randomised controlled trials (in-
cluding quasi-randomised controlled trials and quanti-
tative studies) will be assessed using the Cochrane
Risk of Bias in Non-randomised Studies of Interven-
tions [16]. Studies will be assessed on the domains
below and classified as either low risk, moderate risk,
serious risk, critical risk of bias, or no information to
make a judgement:
Pre-intervention
1. Bias due to confounding
2. Bias in selection of participants into the study
At intervention
3. Bias in classification of intervention
Table 1 Inclusion and exclusion criteria
Characteristic Inclusion criteria Exclusion criteria
Population Participants are pregnant women, over the age of 16 (or where
there is a range of ages included, the majority of participants are
over the age of 16).
Any participants other than pregnant women, or studies that
include only adolescents (under the age of 16).
Intervention Studies testing the effectiveness of a digital intervention (an
intervention that attempts to change pregnant women’s
vaccination behaviour that are delivered via a digital or mobile
device directly to participants) to increase the rate of flu
vaccination (if multiple types of intervention are tested, at least
one of these needs to be a digital intervention, and results must
allow for the rate of vaccination by a digital intervention to be
extracted). Appropriate statistical information about the
effectiveness must be provided
No intervention is tested, none of the tested interventions are
digital
Comparator Studies comparing the effectiveness of a digital intervention (for
example, text message, website, mobile app) to usual care, to a
wait-list comparator, to a non-digital intervention, to a digital inter-
vention that is not about flu vaccination, or to a historical control
group without digital intervention
No comparator, control, or usual care condition is present.
Outcome Outcome being studied is the rate of flu vaccination (either actual
vaccination behaviour or intention to vaccinate)
The rate of flu vaccination is not the outcome measure
Publication
type
Original research studies only Systematic reviews, protocols, commentaries, conference
abstracts
Study design Studies will be RCTs, non-RCTs, quasi-RCTs, or other quantitative
study
Other study designs including quantitative studies that report
audits, surveys and similar, and case series, case studies or case
reports) or those that do not report the rate of flu vaccination
after the implementation of a digital intervention.
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Post intervention
4. Bias due to deviation from intended intervention
5. Bias due to missing data
6. Bias in measurement of outcomes
7. Bias in selection of the reported result
Data synthesis
Key information that is extracted from each included
study will be synthesised. This will consist of descriptive
information about the type and content of intervention
in each condition as presented in the paper. The rate of
flu vaccination will also be extracted from included stud-
ies and will be synthesised and discussed to determine if
digital interventions are effective at increasing flu vaccin-
ation amongst pregnant women. Discussion about the
risk of bias of included papers will also be included.
Data analysis
Statistical information about the rate of flu vaccination
in pregnant women will be presented, to establish
whether digital interventions are more effective at in-
creasing flu vaccination amongst pregnant women, than
other types of interventions or comparison groups.
If studies report the rate of intention to vaccinate instead
of actual vaccination behaviour (vaccination uptake), this
data will be reported instead. Separate analysis for vaccin-
ation and intention to vaccinate will be conducted. If studies
report both vaccination rate and intervention to vaccinate
rate, then the actual vaccination rate will be used.
If sufficient statistical information is provided by included
studies, a meta-analysis will be conducted to establish the
pooled and weighted size of the effect of digital interventions
in increasing flu vaccination amongst pregnant women.
Standardised study effect sizes, using standardised mean dif-
ferences (with 95% confidence intervals) will be calculated
for the increase of flu vaccination rates in digital intervention
conditions, compared to other intervention types or control/
comparison conditions, using a random-effects meta-analysis
model, where the statistical information provided allows. If
applicable, separate meta-analyses will be conducted for vac-
cination intention and actual vaccination uptake. In studies
where insufficient statistical information is include, study au-
thors will be contacted to ask for further information. If no
further information is provided, then the study will be ex-
cluded from the meta-analysis.
Heterogeneity
As it is anticipated that interventions within included
studies will differ, random effects model will be used
for the meta-analysis. Heterogeneity between studies
will be assessed using the chi-squared statistic and I2,
to examine what percentage of variability between
studies is due to heterogeneity rather than chance.
Where I2 is over 40% moderate heterogeneity between
studies is indicated [17].
Subgroup analysis
If sufficient studies are included, and there is sufficient
variation between the types of digital intervention used
to try to increase flu vaccination amongst pregnant
women, subgroup analysis will be performed to deter-
mine which type of digital intervention (for example,
comparing text messages, mobile apps, websites) has the
greater effect on increasing flu vaccination amongst
pregnant women.
If there are sufficient studies, and sufficient variation
between studies, additional sub-group analysis will be
performed to determine the rate of self-reported flu vac-
cination verses validated flu vaccination (from medical
records). This will be compared with the combined rate
of flu vaccination, to determine if there is any difference
between the rate depending on the way it is measured.
If there is sufficient variation in the risk of bias ratings of
included studies, sensitivity analysis will be performed to de-
termine whether results of the meta-analysis would change if
high-risk studies were removed from the analysis.
Publication bias
Funnel plots will be examined to identify the presence of
publication bias. If missing studies as a result of publication
bias are detected, a Trim and Fill analysis will be completed
to account for the missing studies in the effect size [18].
Discussion
Digital healthcare interventions are increasing in popular-
ity and use, contributed by the increase in accessibility of
technology and internet use. Examining the effectiveness
of such interventions for flu vaccination amongst pregnant
women provides useful insight into the research area.
Limitations
The inclusion criteria set may restrict the number of
studies that are eligible for the review. The review is
examining only one type of vaccination (flu vaccination)
in one population group (pregnant women), which will
limit the number of papers, but will provide vital infor-
mation about the potential role that digital interventions
can play in increasing the uptake of flu vaccination for
this vulnerable patient group.
Flu vaccination uptake is lower in pregnant women from
low socio-demographic groups [19–21]. There is the possi-
bility that a digital intervention is beyond the reach of some
pregnant women within this lower socio-demographic group
which may further increase the divide between pregnant
women that do and do not have the flu vaccination.
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Strengths
To date, no review has examined the effectiveness of
digital interventions in increasing flu vaccination uptake
amongst pregnant women. A recent review has examined
interventions that have been used to increase flu vaccination
uptake, but current advancements in technology and internet
use, and previous demonstrated effectiveness of digital health
interventions [22, 10–12], it is relevant and timely to exam-
ine digital flu vaccination interventions.
Potential implications
This review has the potential to increase current know-
ledge about whether digital interventions are likely to be
an effective means of increasing flu vaccination amongst
pregnant women and will hopefully highlight which
modes of digital interventions are most effective. This
knowledge will inform the design of future interventions,
by allowing the most effective mode to be identified and
used for maximum behaviour change.
Registration of review
The protocol for this review was registered on the inter-
national prospective register of systematic reviews
(PROSPERO). Registration number pending. Any
amendments to the protocol will be amended on this
registration.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13643-020-01372-z.
Additional file 1:. PRISMA-P checklist
Additional file 2:. Example search strategy for Medline
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